These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 20517612
21. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial. Saunders P, Tsipouri V, Keir GJ, Ashby D, Flather MD, Parfrey H, Babalis D, Renzoni EA, Denton CP, Wells AU, Maher TM. Trials; 2017 Jun 15; 18(1):275. PubMed ID: 28619061 [Abstract] [Full Text] [Related]
22. An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review. Bougea A, Anagnostou E, Spandideas N, Triantafyllou N, Kararizou E. Einstein (Sao Paulo); 2015 Jun 15; 13(4):627-35. PubMed ID: 26313435 [Abstract] [Full Text] [Related]
24. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Martin-Suarez I, D'Cruz D, Mansoor M, Fernandes AP, Khamashta MA, Hughes GR. Ann Rheum Dis; 1997 Aug 15; 56(8):481-7. PubMed ID: 9306871 [Abstract] [Full Text] [Related]
25. [Cardiac manifestations of rheumatic diseases]. Specker C. Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():40-3. PubMed ID: 16802517 [Abstract] [Full Text] [Related]
27. Neurological involvement in patients with rheumatic disease. Sofat N, Malik O, Higgens CS. QJM; 2006 Feb 22; 99(2):69-79. PubMed ID: 16434469 [Abstract] [Full Text] [Related]
29. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years. Davatchi F, Sadeghi Abdollahi B, Shams H, Shahram F, Nadji A, Chams-Davatchi C, Faezi T, Akhlaghi M, Ghodsi Z, Ashofteh F, Mohtasham N. Int J Rheum Dis; 2014 May 22; 17(4):444-52. PubMed ID: 24314325 [Abstract] [Full Text] [Related]
35. Temporal arteritis: an approach to suspected vasculitides. Harder N. Prim Care; 2010 Dec 15; 37(4):757-66, vi-ii. PubMed ID: 21050956 [Abstract] [Full Text] [Related]
36. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Ann Intern Med; 1997 Jun 01; 126(11):866-73. PubMed ID: 9163287 [Abstract] [Full Text] [Related]
37. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial. Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M, Japanese Study Group for Renal Disease in Children. Pediatr Nephrol; 2010 May 01; 25(5):877-82. PubMed ID: 19902267 [Abstract] [Full Text] [Related]
38. Ocular manifestations of systemic inflammatory diseases. Mohsenin A, Huang JJ. Conn Med; 2012 Oct 01; 76(9):533-44. PubMed ID: 23155672 [Abstract] [Full Text] [Related]
39. [Ocular manifestations in Behçet's disease]. Desbois AC, Terrada C, Cacoub P, Bodaghi B, Saadoun D. Rev Med Interne; 2018 Sep 01; 39(9):738-745. PubMed ID: 29625716 [Abstract] [Full Text] [Related]
40. Systemic vasculitis and the gut. Hatemi I, Hatemi G, Çelik AF. Curr Opin Rheumatol; 2017 Jan 01; 29(1):33-38. PubMed ID: 27684357 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]